行情

IART

IART

英特格拉生命科学
NASDAQ

实时行情|Nasdaq Last Sale

61.18
+0.40
+0.66%
盘后: 61.18 0 0.00% 16:13 09/17 EDT
开盘
60.37
昨收
60.78
最高
61.43
最低
60.22
成交量
31.69万
成交额
--
52周最高
66.41
52周最低
42.14
市值
52.33亿
市盈率(TTM)
52.34
分时
5日
1月
3月
1年
5年

分析师评级

14位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

IART 新闻

  • 美国回购市场陷入疯狂 华尔街无所适从
  • 新浪财经综合.40分钟前
  • 搜狐回应撤回畅游收购提议传闻:未撤回 消息理解有误
  • 新浪科技.58分钟前
  • 美联储十年来首次启动回购平息利率飙升 重启QE快了?
  • 澎湃新闻.1小时前
  • Adobe降低本季度营收预期 广告部门销售不振是主因
  • 界面.2小时前

更多

所属板块

医疗设备、用品及经销
+0.43%
医疗设备和用品
+0.55%

热门股票

名称
价格
涨跌幅

IART 简况

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.
展开

Webull提供Integra Lifesciences Holdings Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。